Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

PDSB PDS Biotechnology Corporation

3,17

0,31 (10,84%)

26 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

PDS Biotechnology (NASDAQ:PDSB)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more PDS Biotechnology Charts.

PDS Biotechnology (NASDAQ:PDSB)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more PDS Biotechnology Charts.

News PDS Biotechnology Corporation

Form 8-K - Current report
Mittwoch 12 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 23 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 23 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 22 Januar 2024 (5 Monate vor) • Edgar (US Regulatory)

PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
Montag 22 Januar 2024 (5 Monate vor) • GlobeNewswire Inc.

PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
Dienstag 16 Januar 2024 (5 Monate vor) • GlobeNewswire Inc.

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Montag 4 Dezember 2023 (7 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 4 Dezember 2023 (7 Monate vor) • Edgar (US Regulatory)

PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Dienstag 28 November 2023 (7 Monate vor) • GlobeNewswire Inc.

Weitere PDS Biotechnology Corporation News-Artikel

Dryden Gold (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen